Cellular pH gradient in tumor versus normal tissue: Potential exploitation for the treatment of cancer

被引:4
|
作者
Gerweck, LE
Seetharaman, K
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although limited data exist, electrode-measured pH values of human tumors and adjacent normal tissues, which are concurrently obtained by the same investigator in the same patient, consistently show that the electrode pH (believed to primarily represent tissue extracellular pH) is substantially and consistently lower in tumor than in normal tissue. In contrast, the P-31-magnetic resonance spectroscopy estimated that intracellular pH is essentially identical or slightly more basic in tumor compared to normal tissue, As a consequence, the cellular pH gradient is substantially reduced or reversed in tumor compared to normal tissue: in normal tissue the extracellular pH is relatively basic, and in tumor tissue the magnitude of the pH gradient is reduced or reversed. This difference provides an exploitable avenue for the treatment of cancer. The extent to which drugs exhibiting weakly acid or basic properties are ionized is strongly dependent on the pH of their milieu. Weakly acidic drugs which are relatively lipid soluble in their nonionized state may diffuse freely across the cell membrane and, upon entering a relatively basic intracellular compartment, become trapped and accumulate within a cell, leading to substantial differences in the intracellular/extracellular drug distribution between tumor and normal tissue for drugs exhibiting appropriate pKas.
引用
收藏
页码:1194 / 1198
页数:5
相关论文
共 50 条
  • [21] Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment
    Machado, Amanda de Barros
    dos Reis, Vania
    Weber, Sebastian
    Jauckus, Julia
    Brum, Ilma Simoni
    Corleta, Helena von Eye
    Strowitzki, Thomas
    Capp, Edison
    Germeyer, Ariane
    ONCOLOGY LETTERS, 2016, 12 (05) : 3626 - 3632
  • [22] Assessment of normal tissue objectives in RapidArc treatment for cervical cancer
    Athulya, P.
    Manna, Sumanta
    Singh, Sharad
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2024, 23
  • [23] Pharmacologic Ascorbate as Radioprotector of Normal Tissue in Pancreatic Cancer Treatment
    Chen, Gloria Y.
    Carroll, Rory S.
    Steers, Garett J.
    Stolwijk, Jeffrey M.
    O'Leary, Brianne R.
    Cullen, Joseph J.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S153 - S153
  • [24] The normal tissue sparing potential of adaptive strategies in radiotherapy of bladder cancer
    Wright, Pauliina
    Redpath, Anthony Thomas
    Hoyer, Morten
    Grau, Cai
    Muren, Ludvig Paul
    ACTA ONCOLOGICA, 2008, 47 (07) : 1382 - 1389
  • [25] TUMOR STROMA - A POTENTIAL TARGET FOR CANCER-TREATMENT
    THIERY, JP
    M S-MEDECINE SCIENCES, 1994, 10 (05): : 505 - 506
  • [26] MECHANISM OF DIFFERENTIAL RADIATION PROTECTION OF NORMAL VERSUS TUMOR TISSUE BY WR-2721 IN TUMOR BEARING MICE
    KOLLMANN, G
    YUHAS, J
    LEON, S
    SHAPIRO, B
    RADIATION RESEARCH, 1973, 55 (03) : 603 - 603
  • [27] Treatment planning comparison on normal tissue complication probability and tumor control probability in the preoperative pelvic irradiation for rectal cancer
    Chu, K.
    Wang, L.
    Chao, L.
    Huang, D.
    Hsia, C.
    Yeh, K.
    Lee, Y.
    Yen, S.
    Chao, M.
    MEDICAL PHYSICS, 2007, 34 (06) : 2500 - 2500
  • [28] Targeting the pH regulators in the tumor microenvironment for ovarian cancer treatment.
    Kulshrestha, Arpita
    Katara, Gajendra K.
    Schneiderman, Sylvia
    Riehl, Valerie E.
    Young, Alexandria N.
    Levine, Shayna
    Ibrahim, Safaa
    Bilal, Mahmood
    Gilman-Sachs, Alice
    Beaman, Kenneth D.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 113 - 113
  • [29] Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy
    Asgharzadeh, Mohammad Reza
    Barar, Jaleh
    Pourseif, Mohammad M.
    Eskandani, Morteza
    Niya, Mojtaba Jafari
    Mashayekhi, Mohammad Reza
    Omidi, Yadollah
    BIOIMPACTS, 2017, 7 (02) : 115 - 133
  • [30] Tissue transglutaminase as a potential therapeutic target in ovarian cancer tumor microenvironment
    Sima, L.
    Chen, S.
    Cardenas, H.
    Zhao, G.
    Wang, Y.
    Ivan, C.
    Huang, H.
    Zhang, B.
    Matei, D.
    FEBS OPEN BIO, 2022, 12 : 99 - 100